comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-02 17:22:35 - browse：2323

What difference does a day make? Who gets to have gene therapy? And are biotech startups OK?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays. Then, HSBC Managing Director Jonathan Norris calls in to discuss why so many biotech startups are facing financial bridges to nowhere.

For more on what we cover, here’s the story on gene therapy; here’s more on Ipsen’s treatment for FOP; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Maui's cultural, historic landmarks damaged in the devastating wildfires

entertainment

WSS

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Option Care buys Amedisys in $3.6 billion home care deal

Meta looks to target Twitter with a rival app called Threads

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

PhRMA sues HHS over Medicare drug price negotiation

Listen: PBM conflicts, RSV vaccines, & the future of flu season

knowledge

comprehensive

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Option Care buys Amedisys in $3.6 billion home care deal

The cancer drug shortage isn’t new — and neither are the solutions

American woman, child freed after being kidnapped in Haiti last month

Hepatitis C has a cure — but many Americans still lack access to it

Listen: PBM conflicts, RSV vaccines, & the future of flu season

The cancer drug shortage isn’t new — and neither are the solutions

Emergent cuts jobs, executive role in business shake

Peter Hotez and the public health issue of online harassment

Listen: PBM conflicts, RSV vaccines, & the future of flu season

focus

Inside the fall of star MIT scientist David Sabatini

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

South Korea throws huge K

A new study asks: Are we harming blood donors by taking blood?

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Wikipedia

entertainment

leisure time

explore